Jane Street
BIOA

Jane Street’s BioAge Labs BIOA Stock Holding History

Jane Street’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$409K Buy
16,700
+5,800
+53% +$105K ﹤0.01% 8496
2026
Q1 		$191K Buy
+10,900
New +$210K ﹤0.01% 10196

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Jane Street's BIOA Position: Q2 2026 in Review

Jane Street opened a new position in BioAge Labs (BIOA) in Q2 2026: 24,089 shares worth $590K. The stake represents ﹤0.01% of the portfolio and ranks #7639 among its holdings. This is a return to the name: Jane Street previously reported a position in BIOA as recently as Q3 2024.

Jane Street first reported a position in BIOA in Q3 2024 and has held it in 2 quarters since. The position peaked at $896K in Q3 2024. 150 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

  • Jane Street held 24,089 shares of BioAge Labs worth $590K as of Q2 2026.
  • BioAge Labs was a new Jane Street position in Q2 2026.
  • BioAge Labs made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #7639 holding.
  • Jane Street first reported a position in BioAge Labs in Q3 2024 and has held it in 2 quarters since.
  • Jane Street's BioAge Labs position peaked at $896K in Q3 2024.
  • 150 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.